Eli Lilly and CompanyLLYNYSE
LOADING
|||
EV to Sales: Premium Valuation
Above historical average, strong compound growth.
Left:
||||
Enterprise value to sales ratio
Latest
16.11
↑ 84% above average
Average (9y)
8.74
Historical baseline
Range
High:16.11
Low:4.09
CAGR
+14.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 16.11 | +0.6% |
| 2023 | 16.02 | +26.4% |
| 2022 | 12.68 | +29.8% |
| 2021 | 9.76 | +37.3% |
| 2020 | 7.11 | +13.9% |
| 2019 | 6.24 | +10.0% |
| 2018 | 5.67 | +18.1% |
| 2017 | 4.80 | +17.6% |
| 2016 | 4.09 | -16.3% |
| 2015 | 4.88 | - |